6Q3C | Cell Cycle | date | Dec 04, 2018 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Cdk2 In Complex With Fraglite1 | ||||||||||||||
authors | D.J.Wood, M.P.Martin, M.E.M.Noble | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Cyclin-Dependent Kinase 2 Chain: A Synonym: Cell Division Protein Kinase 2,P33 Protein Kinase Ec: 2.7.11.22 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Cdk2, Cdkn2 Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.29 Å | ||||||||||||
ligand | BYZ, OCS | enzyme | Transferase E.C.2.7.11.22 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | FragLites - minimal, halogenated fragments displaying pharmacophore doublets. An efficient approach to druggability assessment and hit generation., Wood D, Lopez-Fernandez JD, Knight L, Al-Khawaldeh I, Gai C, Lin S, Martin MP, Miller D, Cano C, Endicott J, Hardcastle I, Noble M, Waring MJ, J Med Chem. 2019 Mar 12. doi: 10.1021/acs.jmedchem.9b00304. PMID:30860382 |
Data retrieval |
View 6Q3C in 3D |
Visual 3D analysis of 6Q3C |
Structure-derived information |
Sequence-derived information |
Other resources with information on 6Q3C |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |